Covid-19 antiviral drug will be developed in UAE

Abu Dhabi’s Sandooq Al Watan and University of Sharjah join hands for a groundbreaking research project in UAE to help develop COVID-19 antiviral drug.

A post on social media by the Abu Dhabi Media Office specified that the drug development grant is meant for the design of a dual-inhibitor antiviral drug to treat SARS-CoV-2 (COVID-19) “by coupling two major privileged scaffolds, which will lead to blocking major enzymes required for viral infection”.

Hoping for the success of this groundbreaking research project.

Chronic Multi-tasker | Born and raised in UAE